Fingerprint Dive into the research topics of 'Phase I trial of 1,2: 5,6 dianhydrogalactitol (DAGA) (NSC 132-313) administered in a weekly schedule'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
Phase I trial of 1,2: 5,6 dianhydrogalactitol (DAGA) (NSC 132-313) administered in a weekly schedule
E. F. Winton, Charles Vogel, M. R. Moore, S. Sohner
Research output: Chapter in Book/Report/Conference proceeding › Chapter